Catena Biosciences
PrivateLast Round
Seed
Jun 8, 2024
Est. Valuation
$10M
Total Funding Raised
$8.35M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Catena Biosciences operates in Healthcare & Life Sciences and is based in Berkeley, California. Its latest recorded funding round was a Seed round in June 2024.
Catena Biosciences is a biotechnology company that develops novel therapeutics using a proprietary protein conjugation platform called CysTyr™ to create Multi-Payload Conjugates (MPCs) for oncology and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Catena Biosciences Comparables
Compare Catena Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VALANX Biotech | 83% | |
| Taiho Pharmaceutical Co., Ltd. | 78% | |
| Pinotbio | 76% |
For institutional investors. Book with your work email.
Catena Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 8, 2024 | ||||
| Grant | Sep 17, 2021 | ||||
| Seed | Aug 1, 2021 | ||||
| Pre Seed | Apr 21, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Catena Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Iaso Ventures | Seed |
| Pioneer Fund | Seed |
| NIH RADx | Grant |
| Gaingels | Seed |
| BrightEdge | Seed |
| California Innovation Fund | Seed |
| Social Impact Capital | Pre Seed, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 48% MoM.
- Jun 19, 2026
Monthly visitors increased 42% MoM.
For institutional investors. Book with your work email.
Catena Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Catena Biosciences's valuation, stock price, and market status.
Is Catena Biosciences a public or private company?
Catena Biosciences is a private company.
What is the current stock price of Catena Biosciences?
Catena Biosciences is a private company, so its shares have no public market price. Caplight tracks Catena Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Catena Biosciences worth (valuation)?
Catena Biosciences's valuation is estimated at $10.0M based on funding round data.
Can I buy Catena Biosciences stock?
Catena Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Catena Biosciences's last funding round?
Catena Biosciences's most recent funding round was Seed on June 8, 2024.
Who are the main investors in Catena Biosciences?
Key investors in Catena Biosciences include Iaso Ventures, Pioneer Fund, NIH RADx, Gaingels, BrightEdge.
Will Catena Biosciences IPO soon?
No public IPO plans have been announced for Catena Biosciences.
How can I track Catena Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Catena Biosciences's shares on secondary markets.